Zhengbo Song

22PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical infection agents (incl. prions)Tumour immunologyCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 31, 2026
Prognostic value of HALP score in non-small cell lung cancer (NSCLC) patients with first-line chemotherapy combined with immunotherapy: a real-world retrospective study.

|Nov 06, 2025
Tislelizumab plus sitravatinib or anlotinib as maintenance therapy in extensive-stage small-cell lung cancer: Results of two prospective phase II studies.

Sizhe Yu, Hui Li, Hongyang Lu

|Aug 02, 2024
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Chunwei Xu, Zhanhong Chen, Yuanli Xia

|Jan 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Gen Lin, Zhijie Wang, Qian Chu

|Nov 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Dingzhi Huang, Gen Lin, Qian Chu

|Sep 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.

Xingxiang Pu, Chunwei Xu, Qian Wang

Pageof 4

Frequent Collaborators

13 joint publications

Chunwei Xu

8 joint publications

Yong Song

8 joint publications

Chengzhi Zhou

8 joint publications

Wenzhao Zhong